CARDIOLOGY / LETTER TO THE EDITOR
CETP inhibition in the REVEAL trial: could we aim higher?
 
More details
Hide details
1
Halal Research Center of IRI, FDA, Tehran, Iran
2
Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
3
Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4
Department of Clinical Biochemistry, Royal Free Hospital Campus, University College London Medical School, University College London (UCL), London, United Kingdom
5
Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, Lodz, Poland
6
Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland
Submission date: 2018-06-03
Acceptance date: 2018-06-03
Online publication date: 2020-08-10
Publication date: 2020-08-06
 
Arch Med Sci 2020;16(5):1229–1230
 
TOPICS
eISSN:1896-9151
ISSN:1734-1922